Skip to main content

Table 4 Pharmacokinetic parameters of BBA, BBA/CM-β-CD and BBA/FA-PEG-CM-β-CD in plasma of BALB/C nude mice after oral administration (n = 5)

From: A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer

Parameters

Unit

BBA

BBA/CM-β-CD

BBA/FA-PEG-CM-β-CD

Cmax

μg/mL

35.923 ± 0.826

28.545 ± 0.716

29.445 ± 0.536

AUC0-t

μg/mL*h

219.263 ± 5.360

348.252 ± 10.121

373.902 ± 4.735

MRT0-t

h

4.769 ± 0.115

8.454 ± 0.026

8.850 ± 0.065

T1/2

h

3.396 ± 0.791

6.694 ± 1.076

8.617 ± 1.422

CL

mL/h/kg

12.760 ± 0.268

7.337 ± 0.413

6.881 ± 0.699